Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine


  1. Published

    A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study

    Reekie, J., Reiss, P., Ledergerber, B., Sedlacek, D., Parczewski, M., Gatell, J., Katlama, C., Fätkenheuer, G., Lundgren, Jens, Mocroft, A. & Eurosida Study Group, E. S. G., 2011, In: HIV Medicine. 12, 5, p. 259-68 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men

    May, M., Sterne, J. A. C., Shipley, M., Brunner, E., d'Agostino, R., Whincup, P., Ben-Shlomo, Y., Carr, A., Ledergerber, B., Lundgren, Jens, Phillips, A. N., Massaro, J. & Egger, M., 2007, In: International Journal of Epidemiology. 36, 6, p. 1309-1318 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    A large-cohort, longitudinal study determines pre-cancer disease routes across different cancer types

    Hjaltelin, Jessica Xin, Helleberg, M., Jensen, A. B., Brunak, Søren & Lundgren, Jens, 2019, In: Cancer Research. 79, 4, p. 864-872

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    A neutralizing monoclonal antibody for hospitalized patients with Covid-19

    ACTIV-3/TICO LY-CoV555 Study Group, A. L. S. G., 11 Mar 2021, In: New England Journal of Medicine. 384, 10, p. 905-914 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    A new health care index predicts short term mortality for TB and HIV co-infected people

    Roen, A. O., Podlekareva, D., Miller, R. F., Mocroft, A., Panteleev, A., Skrahina, A., Miro, J. M., Cayla, J. A., Tetradov, S., Derisova, E., Furrer, H., Losso, M. H., Vassilenko, A., Girardi, E., Lundgren, Jens, Post, F. A. & Kirk, Ole, 2020, In: International Journal of Tuberculosis and Lung Disease. 24, 9, p. 956-962 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors

    Kirk, O., Lundgren, Jens, Pedersen, C., Mathiesen, L. R., Nielsen, H., Katzenstein, T. L., Obel, N. & Gerstoft, J., 2003, In: Antiviral Therapy. 8, 6, p. 595-602 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    A randomized trial to evaluate continuation versus discontinuation fo lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial

    Fox, Z., Dragsted, U. B., Gerstoft, J., Phillips, A., Kjær, J., Mathiesen, L., Youle, M., Katlama, C., Hill, A., Bruun, J., Clumeck, N., Dellamonica, P. & Lundgren, Jens, 2006, In: Antiviral Therapy. 11, 6, p. 761-770

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial.

    Dragsted, U. B., Gerstoft, J., Youle, M., Fox, Z., Losso, M., Benetucci, J., Jayawwera, D., Rieger, A., Bruun, J., Castagna, A., Gazzard, B., Walmsley, S., Hill, A. & Lundgren, Jens, 2005, In: Antiviral Therapy. 10, 6, p. 735-43

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

    Mocroft, A., Reiss, P., Rakhmanova, A., Banhegyi, D., Phillips, A. N., De Wit, S., Ristola, M., Lundgren, Jens, Grarup, J., Kirk, Ole & EuroSIDA in EuroCoord, E. I. E., Aug 2014, In: Infection: A Journal of Infectious Diseases. 42, 4, p. 757-762 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy

    Paredes, R., Puertas, M. C., Bannister, W., Kisic, M., Cozzi-Lepri, A., Pou, C., Bellido, R., Betancor, G., Bogner, J., Gargalianos, P., Bánhegyi, D., Clotet, B., Lundgren, Jens, Menéndez-Arias, L., Martinez-Picado, J. & The EuroSIDA Study Group, T. E. S. G., 1 Sep 2011, In: Journal of Infectious Diseases. 204, 5, p. 741-52 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...69 Next

ID: 13961